Companies: 10,795·Total market cap: $144.5T
Astellas Pharma Inc.

Astellas Pharma Inc.

ALPMFOTCHealthcare● Active
$14.48
+$0.28(+1.99%)
Market Cap$25.9B
P/E Ratio
52W High$17.85
52W Low$9.34
Overview

Astellas Pharma Inc.(ALPMF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ALPMF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2026-032025-032024-032023-032022-03
Revenue
Revenue$2.153T$1.912T$1.604T$1.519T$1.296T
Cost of Revenue$0.548T$0.349T$0.292T$0.288T$0.253T
Gross Profit$1.605T$1.563T$1.311T$1.230T$1.043T
Gross Margin %(computed)74.55%81.74%81.76%81.01%80.48%
Operating Expenses
R&D Expenses$0.317T$0.328T$0.294T$0.276T$0.246T
G&A Expenses$0.000T$0.843T$0.740T$0.630T$0.549T
Total Operating Expenses$1.183T$1.522T$1.286T$0.945T$0.823T
Operating Income$0.422T$0.041T$0.026T$0.133T$0.220T
Operating Margin %(computed)19.62%2.15%1.59%8.76%16.97%
Interest Income$0.008T$0.008T$0.011T$0.008T$0.006T
Interest Expense$0.014T$0.018T$0.012T$0.009T$0.005T
Income Before Tax$0.379T$0.031T$0.025T$0.132T$0.157T
Income Tax Expense$0.086T($0.020T)$0.008T$0.034T$0.033T
Net Income$0.293T$0.051T$0.017T$0.099T$0.124T
Net Margin %(computed)13.63%2.65%1.06%6.50%9.57%
Per Share & EBITDA
EPS (Basic)$164.57$28.35$9.50$54.24$67.08
Wtd Avg Shares0.002T0.002T0.002T0.002T0.002T
EBITDA$0.618T$0.248T$0.195T$0.337T$0.298T
EBITDA Margin %(computed)28.72%12.97%12.15%22.22%22.98%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · JPY · T

深入了解Astellas Pharma Inc.

关于Astellas Pharma Inc.(ALPMF)损益表

Astellas Pharma Inc.(ALPMF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,ALPMF实现营收$2152.71B,毛利润$1604.88B(毛利率74.55%),净利润$293.37B(净利率13.63%)。

常见问题

ALPMF · 4 问

Astellas Pharma Inc.(ALPMF)2026财年营收为$2152.71B,同比up12.6%。

ALPMF revenueALPMF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09